Loss of Prdm11 accelerates MYC-driven lymphomagenesis, regulating target genes in DLBCL cells such as FOS and JUN. Furthermore, patients with PRDM11-deficient DLBCLs have poorer survival [68]. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.